Updates
-
Treatment with Orencia (abatacept) was effective and well-tolerated at four months in children and adolescents with polyarticular juvenile idiopathic arthritis (pJIA) who were intolerant ... Read more
-
Queen Elsa from ‘Frozen 2’ Inspires Me to Move Out of My Comfort Zone
I loved every moment of seeing “Frozen 2” in the theater, from the visually stunning scenes to the songs that prompted a dance party ... Read more -
FDA Approves RediTrex, an Injectable Form of Methotrexate, for JIA Treatment
The U.S. Food and Drug Administration (FDA) has approved RediTrex, an injectable form of methotrexate, for the treatment of juvenile idiopathic arthritis (JIA), active ... Read more -
New Treatments Needed for Children with JIA, Swedish Study Suggests
Despite the increasing number of treatments, children with juvenile idiopathic arthritis (JIA) still experience disease activity most of the time, real-world data from Sweden ... Read more -
New Medications Needed for Children with JIA, Study Reports
The common use of off-label treatments and high failure with available biologic therapies shows the need for new medications for children in the United ... Read more
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
-
Juvenile Arthritis Is Inconsistent, Not Me
My juvenile arthritis (JA) keeps me guessing. One day, my knee will bother me ... -
FDA Approves Abrilada, Biosimilar to Humira, for JIA and Other Inflammatory Disorders
The U. S. Food and Drug Administration (FDA) has approved Abrilada (adalimumab-afzb), a biosimilar ... -
ADA2 Protein Is Reliable Marker of Macrophage Activation Syndrome in Systemic JIA, Study Suggests
Measuring the blood levels of the protein adenosine deaminase 2 (ADA2) accurately identifies macrophage ... -
Pain and Fatigue Can Cause Sleep Problems for Kids with JA
I had a rough night recently. Despite feeling exhausted, I couldn’t stay asleep. I ... -
Xeljanz Eases Symptoms and Disease Flares in Children with Polyarticular JIA, Phase 3 Trial Shows
Treatment with Xeljanz (tofacitinib) reduces disease flares, improves physical functioning, and significantly eases symptoms of ... -
Children with JIA at Risk for Depression and Anxiety, Lower Quality of Life, Review Suggests
Children with juvenile idiopathic arthritis (JIA) experience anxiety and depression at higher rates than ...
Systemic Arthritis and Prolonged Corticosteroid Use Associated with Growth Impairment in Juvenile Idiopathic Arthritis
News
A recent study showed that children with juvenile idiopathic arthritis (JIA) now have similar growth and weight gain as children in the general population. Nonetheless, about 1 in 10 JIA children with systemic arthritis, uncontrolled disease, or prolonged use of ... Read more